A FOCUS ON
INVESTIGATOR INITIATED TRIALS In March 2021 a dedicated Investigator Initiated Trials (IIT) team was formed to manage Icon’s growing global IIT portfolio. The appointment of an Investigator Initiated Trials and Grants Manager, Mel Grand, and a dedicated IIT Project Manager, Lloyd Smyth, has reinvigorated the focus of IITs across Icon, aligned processes and supported the establishment of a Group framework to deliver a quality international IIT program.
MEL GRAND
LLOYD SMYTH
Investigator Initiated Trials and Grants Manager
Investigator Initiated Trials Project Manager
Mel has over 20 years’ experience in the oncology
Lloyd is a qualified radiation therapist who brings
sector, having worked as a radiation therapist, project
experience in both academic and clinical research to the IIT
manager and clinical trials manager. She brings an
program. He has a strong interest in the use of innovative
extensive depth of clinical knowledge combined with
techniques to treat cancer, having previously completed
high level project management, including large trial
his PhD in the discipline of radiation biology through work
portfolios and the management of government grants,
at the Australian Synchrotron. Lloyd’s publication record
as well as a strong focus on quality and research
spans clinical and translational domains, and he brings
ethics and education.
skills in data and project management to support the development of the IIT portfolio.
Connect on LinkedIn Connect on LinkedIn
32
ICON ANNUAL RESEARCH REPORT 2021
